NR5A2 and metabolic dysfunction-associated steatohepatitis: NR5A2, a crucial transcription factor involved in liver lipid metabolism, remains poorly understood in its association with NASH due to challenges posed by ineffective antibodies, the presence of different isoforms, and the cell survival issues associated with knockout models [6, 40].